Product Information
BRIMONIDINE 0.2% EYE DROP is a generic product labeled by Sandoz Inc., priced at $0.7773 per ML under NDC 61314014305. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2 mg/mL
Manufacturer
Sandoz Inc.NDC
61314014305
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA076254On Market Since
9/17/2003
Pharmacological Classes
Price Statistics
The NADAC for BRIMONIDINE 0.2% EYE DROP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 16.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7773 per ML |
|---|---|
| All-time high | $0.9708 (Nov 13, 2019) |
| All-time low | $0.6907 (May 22, 2024) |
| 52-week high | $0.8447 |
| 52-week low | $0.7695 |
| Median price | $0.8047 |
| Average price | $0.8169 |
| Largest weekly change | +25.0% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BRIMONIDINE 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE 0.2% EYE DROP, manufactured by Sandoz Inc., is $0.7773 per ML (NDC 61314014305), effective Jun 24, 2026.
How has the price of BRIMONIDINE 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for BRIMONIDINE 0.2% EYE DROP has declined 16.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BRIMONIDINE 0.2% EYE DROP?
Since Nov 28, 2013, the NADAC for BRIMONIDINE 0.2% EYE DROP has ranged from a low of $0.6907 (May 22, 2024) to a high of $0.9708 (Nov 13, 2019), with a median of $0.8047 per ML.
Are there cheaper alternatives to BRIMONIDINE 0.2% EYE DROP?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BRIMONIDINE 0.2% EYE DROP, is $0.4936 per ML — about 36% below BRIMONIDINE 0.2% EYE DROP.
Who manufactures BRIMONIDINE 0.2% EYE DROP?
BRIMONIDINE 0.2% EYE DROP (NDC 61314014305) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification